Glycogen metabolism has been the subject of extensive research, but the mechanisms by which it is regulated are still not fully understood. It is well accepted that the ratelimiting enzymes in glycogenesis and glycogenolysis are glycogen synthase (GS) and glycogen phosphorylase (GPh), respectively. Both enzymes are regulated by reversible phosphorylation and by allosteric effectors. However, evidence in the literature indicates that changes in muscle GS and GPh intracellular distribution may constitute a new regulatory mechanism of glycogen metabolism. Already in the 1960s, it was proposed that glycogen was present in dynamic cellular organelles that were termed glycosomas but no such cellular entities have ever been demonstrated. The aim of this study was to characterize muscle GS and GPh intracellular distribution and to identify possible translocation processes of both enzymes. Using in situ stimulation of rabbit tibialis anterior muscle, we show GS and GPh intracellular redistribution at the beginning of glycogen resynthesis after contraction-induced glycogen depletion. We identify a new "player," a new intracellular compartment involved in skeletal muscle glycogen metabolism. They are spherical structures that were not present in basal muscle, and we present evidence that indicate that they are products of actin cytoskeleton remodeling. Furthermore, for the first time, we show a phosphorylation-dependent intracellular distribution of GS. Here, we present evidence of a new regulatory mechanism of skeletal muscle glycogen metabolism based on glycogen enzyme intracellular compartmentalization.Although the primary factors involved in the development of type 2 diabetes mellitus are still unknown, it is clear that insulin resistance of skeletal muscle glucose metabolism plays a key role. A defect in insulin activation of muscle glycogen synthase (GS), 1 a key enzyme in the regulation of glycogen synthesis, is one of the most consistent findings in patients with type 2 diabetes (1, 2). However, since the mechanisms involved in muscle GS activation are still not fully understood, the defective steps in type 2 diabetic subjects have remained unidentified. A better understanding of skeletal muscle glycogen metabolism is needed to understand the primary factors involved in the development of the disease and to identify targets for new therapeutic strategies.The rate-limiting enzymes in glycogenesis and glycogenolysis are considered to be GS and glycogen phosphorylase (GPh), respectively. Both enzymes are regulated by reversible phosphorylation and by allosteric effectors. In vivo, nine GS sites susceptible to phosphorylation have been identified, which are phosphorylated by different protein kinases. In rabbit skeletal muscle GS, two sites (2 and 2a) are located near the N terminus, whereas the remaining seven (sites 3a-c, 4, 5, 1a, and 1b) are located within 100 residues of the C terminus. Phosphorylations at different sites have different effects on the enzyme activity. The most important sites involved in GS intrin...